Trial Profile
Efficacy of omalizumab in patients with severe allergic asthma and severe non-allergic asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jan 2016
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma; Asthma
- Focus Therapeutic Use
- 12 Jan 2016 Status changed from not stated to completed.
- 12 Jan 2016 New trial record